2014
DOI: 10.3109/02688697.2014.976173 View full text |Buy / Rent full text
|
|

Abstract: SRS appears to offer a reasonable rate of facial nerve preservation and tumor control for patients with small-to-medium-sized FNS. Considering the published outcomes achieved with resection, RS may be the preferred first-line treatment for these tumors.

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
8
0

Publication Types

Select...

Relationship

0
0

Authors

Journals